Diagnostics news


Optical sensor measures blood glucose through skin
Swiss research institute Empa and University Hospital Zurich have developed an optical sensor that measures blood sugar levels through the skin, without taking any blood. 23 Jan 2015

DNA Electronics acquires nanoMR for $24m
DNA Electronics Ltd, the inventors of semiconductor DNA sequencing technology, has completed the acquisition of nanoMR Inc. an Albuquerque-based developer of a system for rapid isolation of rare cells in the bloodstream, for approximately $24 million.

ICR develops avatars to display important cancer cell features to aid diagnosis
The Institute of Cancer Research, London has developed new software to visualise data generated by imaging of cancer cells in a more intuitive way than graphs or charts. The program called PhenoPlot generates ‘avatars’ of cancer cells based on imaging data collected by robotic microscopes. 12 Jan 2015

Massachusetts Life Sciences Center grants Cambridge Consultants $1m to develop Ebola diagnostic kit
Massachusetts Life Sciences Center has awarded Cambridge Consultants and non-profit enterprise Diagnostics For All $1m to develop a low-cost point-of-care device for testing patients in remote areas for the Ebola virus. 5 Jan 2015

Portable blood analyser detects Ebola virus in 75 minutes
STMicroelectronics and Clonit, in collaboration with Italy’s National Institute for Infectious Diseases Lazzaro Spallanzani, have developed in a few weeks a prototype portable analyzer able to identify the presence of the Ebola virus in less than 75 minutes. 12 Dec 2014

Prostate cancer diagnosed from tissue sample in 90 seconds
The Fraunhofer Institute for Ceramic Technologies and Systems (IKTS) in Dresden has developed a
device that can identify cancerous prostate tissue from a biopsy within one and a half minutes by using laser stimulated fluorescence. 14 Nov 2014

OJ Bio develops prototype hand-held disease diagnostics lab
Newcastle company OJ Bio has successfully completed the prototype development of a portable wireless point-of-care diagnostic system that accurately and quickly identifies the presence of a range of viruses and bacteria in patient fluid samples. 7 Nov 2014

FIND and QuantuMDx partner to develop rapid genome-based diagnostics for tuberculosis
Swiss NGO FIND is joining forces with UK diagnostics developer QuantuMDx Group to develop a combined solution for the rapid detection of tuberculosis and determination of drug resistance.

New method for creating biological sensors on silicon chips
Scientists from Chile and Germany  have developed a novel process to layer two readily available chemicals on a silicon substrate to mimic a cell membrane and give the ability to link biological processes to electronics. 30 Oct 2014

Welch Allyn to add Gentag's NFC wireless technology to medical devices
Medical diagnostics device company Welch Allyn and Gentag, a pioneer in disposable wireless biosensors, have entered into an agreement to bring to market near field communications technology for medical devices and sensors 29 Oct 2014

Sound generated by knee joint shows extent of osteoarthritis
A team led by Lancaster University has developed a technique that uses sound waves and computer software to assess the state of osteoarthritis in the knee. 29 Oct 2014

Lung cancer can stay dormant for 20 years until triggered by genetic faults
Researchers at Cancer Research UK have discovered that lung cancers can lie dormant for over 20 years until genetic faults trigger sections to grow and the cancer becomes aggressive. 13 Oct 2014

Genetic test identifies people at higher risk of atrial fibrillation and stroke 
People who are genetically predisposed to develop atrial fibrillation, which increases risk of stroke, can be identified with a blood test according to research at Lund University in Sweden. 13 October 2014

Paris Public Hospitals Group and Magnisense partner to develop tests for cardiovascular diseases
French hospital group AP-HP, (Assistance Publique-Hôpitaux de Paris), and diagnostics technology developer Magnisense have signed a partnership agreement to develop rapid portable diagnostic tests for cardiovascular diseases. 9 Oct 2014

QuantuMDx announces prototype handheld lab for rapid DNA diagnostics
Newcastle-based medical device developers QuantuMDx Group has announced the successful production of their first fully-integrated sample-to-result working prototype of Q-POC, a handheld lab that delivers DNA-based medical diagnosis in minutes. 11 Sep 2014

New technique to test for prostate cancer
A team of researchers at Guangdong Medical College in China has demonstrated the potential of a new test to detect prostate cancer combining surface-enhanced Raman scattering (SERS) with a new technique called support vector machine (SVM). 9 Sept 2014

Roche launches automated molecular diagnostic systems for blood and blood plasma screening
Roche has launched two integrated and fully automated molecular testing systems for blood and plasma donor screening, the cobas 6800 and 8800, based on Nobel-prize winning PCR technology. 2 Sept 2014

Haemostasis management device used in Afghanistan war zones approved by NICE
The ROTEM point of care blood analyser which has been used to manage major bleeding in soldiers in Afghanistan has now been recommended by NICE for use by the NHS. 29 Aug 2014

Primerdesign announces lowest cost DNA analytics device for health, veterinary, food and biothreat testing
Southampton University spinoff Primerdesign Ltd has announced the launch of what it claims is the world’s most affordable device for DNA diagnostics. The genesig q16 uses real-time PCR analysis to test DNA using a range of over 400 testing kits

Rapid Biosensor Systems appoints chair in move to IPO
Cambridge company Rapid Biosensor Systems Ltd has appointed John Reynolds OBE as Executive Chairman to take it to the next stage of growth. 12 Aug 2014

KTH designs device to sort cells by elasticity properties
Researchers at Sweden's KTH The Royal Institute of Technology have used computational simulations to propose a microfluidic device that can sort cells according to their elasticity. This could offer a more reliable alternative for detecting disease biomarkers. 14 Jul 2014

Plasmonic biosensors make highly sensitive diagnostic devices
A new type of highly-sensitive and low-cost sensor, called a plasmonic biosensor, could detect a range of biomarkers that diagnose diseases at an early stage. 8 July 2014

Clearbridge BioMedics launches device that isolates circulating tumour cells from blood
Clearbridge BioMedics has launched a new cancer diagnostic device, the ClearCell FX System, which is able to isolate and capture circulating tumour cells (CTCs) from a blood sample. 5 Jun 2014

QuantuMDx closes $8.42m funding for prototyping handheld DNA diagnostics device
The Newcastle-based diagnostics developer has announced it has closed an $8.42m funding round syndicated with philanthropist private investors and the University of Newcastle upon Tyne. 4 Jun 2014

MRI-guided biopsy for brain cancer improves diagnosis
Neurosurgeons at UC San Diego Heath System have combined real-time MRI technology with non-invasive cellular mapping techniques to develop a new biopsy method that increases the accuracy of brain cancer diagnosis. 6 May 2014

ValiRx cancer screening gene biomarker granted Japanese patent
ValiRx Plc has announced that NAV3, its cancer screening test gene biomarker has received patent approval by the Japanese patent office (JPO). 6 May 2014

Nanosensors detect cancer from breath
A collaboration of researchers in Switzerland and Japan has developed portable cancer detection units using coated nanocantilevers for diagnosis from breath. 25 Apr 2014

Codasip secures $2.8m investment for ASIP technology
Application-specific processor developer Codasip, has announced that it has closed its first round of public funding from Czech venture capital firm Credo Ventures. 25 Apr 2014

Blood test could predict Alzheimer's three years in advance of symptoms showing
A team of US researchers is patenting a blood test for Alzheimer's or mild cognitive impairment (MCI) based on 10 lipid biomarkers associated with the diseases. 10 March 2014

Siemens Healthcare Diagnostics partners with Pfizer to develop diagnostic tests
Siemens Healthcare Diagnostics and Pfizer are partnering to develop in vitro diagnostic tests for therapeutic products across Pfizer’s pipeline. 4 Feb 2014

QuantuMDx launches crowdfunding campaign to help eliminate malaria with handheld lab
DNA diagnostics company QuantuMDx will launch an Indiegogo crowdfunding campaign to support malaria eradication worldwide by further developing and trialling their handheld laboratory which can identify malaria DNA in 15-minutes. 9 Jan 2014

University of Surrey device identifies cancerous cells by electrical properties
A University of Surrey research team has developed an innovative device that can differentiate between normal and unhealthy cells by analysing their electrical properties. 3 Jan 2013

Ultrasound microscope identifies cancerous tissue by acoustic profile
Professor Naohiro Hozumi of Toyohashi University of Technology has developed an ultrasonic microscope to differentiate living tissue and cell specimens for medical purposes. 3 Jan 2013

CEO of QuantuMDx awarded OBE in New Year's Honours list
QuantuMDx Group’s CEO and Co-Founder Elaine Warburton has been awarded an OBE in the New Year’s Honours list 2014 for her services to health innovation over the last 25 years. 3 Jan 2013

Hunt for RNA biomarkers for prostate cancer and other diseases
The RIBOLUTION project in Germany is developing a platform for the identification and validation of RNA biomarkers for prostate cancer and selected diseases based on genome-spanning screening. 19 Dec 2013

Paper-based diagnostic test and phone app check children for vaccination
Cambridge Consultants is working with US non-profit organisation Diagnostics For All to demonstrate a mobile phone application that can read a simple paper-based test for whether a child has been immunised. 11 Dec 2013

Device measures risk of infection from a blood drop in minutes
A team at the BioMEMS Resource Center at Massachusetts General Hospital has developed a device to rapidly test for inflammation in response to infection. 11 Dec 2013

Trinity Biotech exhibits cardiac diagnostics point-of-care system at MEDICA
Trinity Biotech is displaying its new 15-minute-analysis Meritas Troponin I (TnI) point-of-care test in Dusseldorf this week. 20 Nov 2013

Aerotel showcases smallest hand-held ECG monitors at MEDICA
Aerotel Medical Systems is presenting two new models of what it claims are the world’s smallest and most accurate hand-held ECG monitors at Medica 2013. 20 Nov 2013

ARC launches non-touch medical thermometers at MEDICA
Belfast company ARC is launching  four new highly accurate non-touch thermometers at MEDICA this week. 20 Nov 2013

Capillary Film Technology launches microfluidic device manufacturing technology at MEDICA
Biotechnology developer Capillary Film Technology Ltd (CFT) has announced the launch of a new fluoropolymer Micro Capillary Film (MCF) technology. 20 Nov 2013

TB drug resistance detected in under 15 minutes
Newcastle-based diagnostics company QuantuMDx has been awarded a £1m grant by the UK Technology Strategy Board to develop a new rapid test, called Q-TB, to diagnose TB and test for drug resistance. 18 Nov 2013

Foetal heart monitor uses magnetism to identify abnormal heart rhythms
A device that records the natural magnetic activity of the heart of foetuses can help identify abnormal heart rhythms in unborn babies. 14 Nov 2013

New hope for blood test to catch pancreatic cancer early
A simple blood test to detect gene fragments unique to pancreatic cancer cells could be on the horizon following promising results in a small preliminary study at Johns Hopkins Medicine in the US. 11 Nov 2013

New software detects genetic diseases 20 times more accurately
A new set of computer programs developed at the iMinds research institute at KU Leuven can rapidly identify hereditary diseases from the vast amounts of data generated by genetic analysis. 30 Oct 2013

Cepheid launches next-generation Xpert Flu diagnostic test
Cepheid has launched its next generation Xpert Flu test for the GeneXpert System, offering on-demand STAT testing for triage, outbreaks, emergencies and high risk patient management. 28 Oct 2013

IBM develops microfluidic probe to diagnose cancer in tissue samples
IBM scientists are collaborating with pathologists at the University Hospital Zürich to test a prototype device called a microfluidic probe for accurately diagnosing different types of cancer. 28 Oct 2013

Nanodiamonds monitor molecular processes from inside cancer cells
The EU-funded project Dinamo aims to develop a sensing platform for real-time monitoring of biomolecular processes in living cancer cells using fluorescent diamond particles. 28 Oct 2013

QuantuMDx wins NE innovation award for handheld DNA sequencer
Newcastle-based diagnostics company QuantuMDx has been awarded the Insider's 'Made in the North East' Life Sciences trophy in recognition of its ground-breaking handheld DNA sequencer. 10 Oct 2013

Skuldtech secures €1m to develop blood biomarker test for Alzheimer's disease
French biotechnology company Skuldtech has secured €1m in funding from Bpifrance (French public financing structure) to develop a blood biomarker test for Alzheimer's disease. 11 Sept 2013

Raman laser highlights tumour cells in brain tissue during surgery
A new laser-based technology can identify cancerous cells during surgery, enabling surgeons to make sure they remove all the cells that could develop into a new tumour. 10 Sept 2013

Colour-changing dots detect blood-borne bacteria
A team at the University of Illinois has developed a cheap disposable device containing a chemical sensing array (CSA) that can rapidly identify bacteria from the signature chemicals that they give off. 10 Sept 2013

Siemens launches SPECT-CT system for high resolution molecular imaging
Siemens Healthcare's xSPECT system, the Symbia Intevo, combines the high sensitivity of single-photon emission computed tomography (SPECT) with the high specificity of CT to generate high resolution and, for the first time, quantitative images. 19 Aug 2013

Rapid tissue analysis shows stage of bowel cancer for fine tuning treatment
Researchers at Imperial College have measured the stage of a tumour by analysing the chemicals produced by the tumour cells using high-resolution magic angle spinning nuclear magnetic resonance spectroscopy. 15 Aug 2013

RNA test could detect Alzheimer's disease
A new RNA-based blood test can distinguish between people with Alzheimer's disease and healthy controls. This type of test could be used to help diagnose the disease and other degenerative disorders. 31 July 2013

New breast cancer test is better at diagnosing need for chemotherapy
A new genetic test can better determine the likelihood of recurrence of a common form of breast cancer and help decide on the need for chemotherapy. 2 July 2013

Blood test for pregnant women diagnoses Down's Syndrome in foetus
A non-invasive test that analyzes foetal DNA in a pregnant woman’s blood can accurately detect Down’s syndrome and other genetic foetal abnormalities in the first trimester. 7 June 2013

Microfluidic device separates non-spherical bioparticles for rapid disease diagnosis
A team at the National University of Singapore (NUS) has developed a novel microfluidic device that separates and detects non-spherical bioparticles such as pathogenic bacteria and malaria-infected red blood cells. 23 Apr 2013

Nanosensor detects cancer cells
A nanosensor that can detect cancerous skin cells by identifying mutated RNA has been developed by the Swiss Nanoscience Institute of the University of Basel and the Ludwig Institute for Cancer Research in Lausanne. 27 Feb 2013

Patients at risk from inaccurate antibiotic test kits used in hospital pathology labs
An investigation by the British Medical Journal (BMJ) has found that one of the world’s leading producers of diagnostic tests has been falsely marketing one of their products. 13 Feb 2013

Nurses at the forefront of genomics in healthcare
A special Genomics Issue of the Journal of Nursing Scholarship addresses genetic applications that are essential to advancing nursing knowledge and patient care. 5 Feb 2013

Rapid identification of lung infection by analysing volatile compounds in breath
The chemical ‘fingerprints’ given off by specific bacteria infecting lungs can be rapidly identified by a type of mass spectrometry. 16 Jan 2013

Q-Cancer awarded £1.4m to develop QuantuMDx benchtop tumour profiler
The Q-CANCER project will integrate QuantuMDx Group’s rapid on-chip lab processes and develop the first sub-20 minute tumour profiler. 23 Nov 2012

Card-sized device can detect diseases from tiny samples in minutes
The card-sized device, which needs no power, lays the groundwork for early-stage point-of-care diagnosis of diseases such as cancers and Alzheimer's. 22 Nov 2012

Blackpool hospitals use genetic testing to reduce MRSA
Blackpool Teaching Hospitals NHS Foundation Trust has introduced rapid screening for the superbug MRSA of all emergency admissions patients, and both MRSA and MSSA for surgical patients admitted through A&E. 22 Nov 2012

SpinChip microfluidics device analyses blood at the point of care
Norwegian company SpinChip has developed a microfluidics-based chip contained in a portable device that analyses blood samples at the point of care and provides immediate results. 14 Nov 2012

DNA sequencing tracks source of MRSA in hospital infection
A Cambridge-based team has used advanced DNA sequencing technologies to confirm the presence of an ongoing outbreak of MRSA at Addenbrooke's Hospital, Cambridge, in real time. 14 Nov 2012

Hand-held device can diagnose flu virus strains in minutes
Newcastle-based OJ-Bio has secured funds to further develop a device for the rapid, simple and low cost diagnosis of flu and other viruses. 13 Nov 2012

Zilico secures further £750K funding for cervical cancer test
Zilico Ltd has secured £750K investment from The North West Fund for BioMedical. This follows £1m invesetment announced in June 2012. 6 Nov 2012

New ‘traffic light’ test could help GPs diagnose liver disease earlier
The Southampton Traffic Light (STL) test combines several different tests and clinical markers that are given a score that indicates the patient’s likelihood of developing liver fibrosis and liver cirrhosis. 5 Sept 2012

MedMira wins $4.2m US army contract to commercialize rapid test for HIV and hepatitis
MedMira will advance and commercialize a multiple rapid test that will simultaneously detect HIV-1/2, Hepatitis B and C antibodies within three minutes using just a small drop of blood.  23 July 2012

New semen test for testicular cancer
The Rigshospitalet in Copenhagen has found a new and simple way of detecting testicular cancer before it starts, by detecting markers in a sperm sample.

New diagnostic tool increases the value of Kancera's ROR cancer treatment
Kancera and the Karolinska Institute have developed antibodies that permit the development of a diagnostic tool to identify cancer patient response to treatment using Kancera’s ROR inhibitors. 25 June 2012

Plessey launches ultra-low cost version of EPIC sensor
Plessey Semiconductors has released an ultra-low cost version of its award-winning EPIC sensor that provides remote electric field sensing for high volume consumer markets. 15 June 2012

Miniature magnetic sensor opens new era for neurology
A new type of magnetic field sensor, called a chip-scale atomic magnetometer (CSAM), uses miniaturized optics for measuring absorption changes in a rubidium gas cell caused by magnetic fields. 12 June 2012

High speed bench-top sequencing to revolutionise hospital infection control
A new generation of bench-top DNA sequencers can quickly and cheaply map the entire genetic codes of bacteria causing life-threatening infections. 11 June 2012

Electronic sensor can detect prostate cancer cells
Scientists at the Barcelona University have developed the main components of a biosensor containing several hundred nanometric sized optoacoustic biosensors and that can detect cancer cells in urine. 4 June 2012

Enzyme-coated gold nanoparticles make ultra-sensitive disease detectors
Enzyme-coated gold nanoparticles can detect disease biomarkers at several orders of magnitude lower concentrations than current tests and will make it possible to detect a range of diseases earlier. 30 May 2012

Stago launches rapid HIT exclusion test in the UK
Stago has launched a simple test that will rapidly exclude heparin-induced thrombocytopenia (HIT), following use of heparin in surgery, in just 10 minutes. 28 May 2012

Abbott awarded CE mark for PLEX-ID rapid microbial identification system and clinical tests
PLEX-ID, which is based on molecular diagnostic technologies, addresses a significant unmet need for rapid detection and identification of a broad range of microbes that cause infections in patients. 28 May 2012

Idaho Technology receives FDA 510(k) clearance for rapid respiratory pathogen detection system
Idaho Technology, Inc. has announced US FDA 510(k) clearance of five additional pathogens for its FilmArray RP system and the launch in European markets. 28 May 2012

Michelson Diagnostics secures £600k investment for further growth
Michelson Diagnostics has announced a further investment of £607k by shareholders Octopus Investments, Catapult Venture Managers and London Business Angels. 22 Mar 2012

Revolutionary DNA sequencing technique improves diagnosis of muscular dystrophy
Scientists at The University of Nottingham have used massively parallel DNA sequencing to correctly identify muscle-wasting diseases. 7 Mar 2012

Wireless self-propelled chip swims through blood vessels
A tiny, wirelessly powered, self-propelled medical device capable of controlled motion through blood vessels has been developed by electrical engineers at Stanford University. 27 Feb 2012

PneumaScan installed in Hospital Kuala Lumpur
Cambridge company PneumaCare Limited has installed its innovative PneumaScan respiratory assessment device in Hospital Kuala Lumpur. 20 Feb 2012

Influenza virus diagnosed in record time with new genetic test
The test, developed by researchers at the RIKEN Omics Science Center  can detect influenza virus infection in 40 minutes and with one hundred times the sensitivity of conventional methods. 2 Feb 2012

X Prize Foundation announces US$10m prize for developing Star Trek Tricorder
The X Prize Foundation and Qualcomm Foundation have launched the US$10 million Qualcomm Tricorder X Prize to stimulate the development of a multipurpose consumer health diagnostics device. 16 Jan 2012

New decision-support tool provides earlier diagnosis in Alzheimer’s disease
The VTT Technical Research Centre of Finland has developed a decision support tool for objective diagnostics of Alzheimer’s disease as part of the European PredictAD project. 13 Jan 2012

Microvisk wins Healthcare Project of the Year after visitors queue up at Medica
Microvisk Technologies has scooped the Award at the BioNoW Biomedical Awards. It follows the highly successful introduction of the company's CoagMax and CoagLite devices at Medica. 9 Dec 2011

Systagenix launches point of care test for rapid assessment of chronic wounds
Woundchek Protease Status, the first product arising from the collaboration with Alere Scarborough, is the world’s first rapid, point of care test for the assessment of protease activity in chronic wounds. 28 Nov 2011

Endomagnetics raises additional funding for novel cancer diagnostics probe
Cambridge-based Endomagnetics has raised funding totalling £1.8 million. The Company has also announced a move to Cambridge and two new appointments as it expands its operations. 23 November 2011

Oxford Medical Diagnostics achieves detection of 1ppm acetone in breath
Oxford University spinout Oxford Medical Diagnostics has announced that it has achieved a significant target in developing a cost-effective desk-top breath analysis device to diagnose diabetes. 20 Nov 2011

New method for detecting breast cancer uses magnetic particles and SQUID
A new and potentially more sensitive method of detecting breast cancer has been developed that uses tumour-targeting magnetic iron oxide particles and superconducting quantum interference device (SQUID) sensors. 28 Oct 2011

QuantumDX licenses nanostructures for DNA sequencing in hand-held devices
Newcastle-based QuantuMDx Group Limited has signed an exclusive license agreement with US nanotechnology developer Nanosys Inc for several patents and patent applications related to the use of nanostructures for biosensors. 23 October 2011

Cerebrospinal fluid is key to early diagnosis of different types of dementia
Different forms of dementia leave different biochemical fingerprints in the cerebrospinal fluid before any clinical symptoms emerge, researchers at the Sahlgrenska Academy in Sweden have discovered. 11 Oct 2011

Max Medical to show new range of diagnostic and monitoring devices at Medica 2011
Max Medical are displaying a range of new products at Medica in Dusseldorf in November, including first aid kits, blood glucose monitoring devices, and blood pressure monitors. 29 Sept 2011

New aptamer based sensors will lead to cheap ultra-portable blood testing
The University of Toledo in Ohio has developed a low-cost, portable technique that is able to quickly and reliably detect specific proteins in a sample of human blood. 20 September 2011

UCLA creates cheap light-weight lens-free microscope using holograms
The prototype weighs about as much as a medium-sized banana and fits in the palm of a hand. It could be used to improve healthcare in remote areas of the world with little access to expensive diagnostic equipment. 20 Sept 2011

Microvisk introduces world’s first MEMS-based diagnostics system in the US
North Wales-based Microvisk Technologies has introduced its handheld devices that monitor the blood clotting status of patients to the US market. 31 August 2011

Dogs can detect lung cancer from breath
Sniffer dogs could be used for the early detection of lung cancer from the breath of patients, according to researchers at Schillerhoehe Hospital in Germany. 25 August 2011

Simple blood oxygen test identifies newborns with dangerous heart defects
A simple test to measure blood oxygen in newborns has been shown to identify babies with life-threatening congenital heart defects, a major cause of infant mortality in the developed world. 13 August 2011

Innovative diagnostic devices win NHS Smart Solutions competition
A cardiovascular screening system that uses retinal images, new devices to detect blocked leg arteries and neuropathy in diabetics, and a service which uses a monitoring device to diagnose sleep apnoea in patients’ own homes, are the winners of an NHS competition. 11 August 2011

Plessey Semiconductors wins award for novel electric field sensor technology
The EPIC sensor is a completely new area of sensor technology that measures changes in an electric field in a similar way to a magnetometer detecting changes in a magnetic field. 9 June 2011

New marker for prostate cancer gives hope for more accurate diagnosis than PSA test
Researchers at Uppsala University have discovered a promising new marker for diagnosing prostate cancer. Their unique method could lead to more reliable diagnoses and fewer unnecessary operations. 18 May 2011

Xpert test for TB proven fast and effective in developing country settings
The effectiveness of the Cepheid Xpert MTB/RIF test for tuberculosis and rifampicin resistance in realistic healthcare field conditions has been reported in a study in The Lancet. 4 May 2011

New weapons needed to tackle growing threat of tuberculosis
Leading experts from 12 countries discussed the growing threat from tuberculosis at a conference at the Institute of Tropical Medicine (ITM) in Antwerp this month. 28 March 2011

New EU-funded projects to find new cures for tuberculosis
To mark World Tuberculosis Day the European Commission has announced that it is supporting new projects aimed at finding new cures for the disease. 28 March 2011

Bruker launches portable toxin identification system
The benchtop, push-button pTD system is intended for smaller, field and mobile laboratories for use by non-expert operators in homeland security applications. 17 Feb 2011

Caliper and Seegene partner to provide multiplex molecular diagnostics products
Caliper Life Sciences, Inc. and Seegene, Inc. have entered into a strategic partnership to enable Seegene's SeePlex multiplex diagnostic assays to run on Caliper's innovative LabChip Dx platform. 31 Jan 2011

Caliper launches LabChip Dx for molecular diagnostics
The LabChip Dx system uses the company's proprietary microfluidic technology and is aimed at clinical research laboratories developing molecular diagnostic tests. 31 Jan 2011

Sepmag awarded Chinese patent for homogenous biomagnetic separation
The company's novel technique applies less pressure on particles and guarantees users consistently reproducible results in their in vitro diagnostics kits. 24 Jan 2011

Mobile platform for fast sepsis diagnosis
A new credit-card-sized diagnostic platform being developed at the Fraunhofer Institute for Cell Therapy and Immunology will be able to diagnose sepsis in as little as an hour. 6 Jan 2011

Portable device for breast cancer screening moves closer to market
A new portable device that detects breast cancer based on tissue elasticity has come a step closer to market with its licensing by a medical device company. 10 Dec 2010

DARPA awards Georgia Tech $4.3m to develop biochemical sensors
The US Defense Advanced Research Projects Agency (DARPA) has awarded the Georgia Institute of Technology $4.3m to develop a new class of sensors able to detect multiple biological and chemical threats simultaneously. 10 Dec 2010

Abbott joins Clinton Health Initiative to improve HIV testing in Africa
Abbott will supply its RealTime HIV-1 qualitative test kits to healthcare facilities and also offer the capability to collect and process samples using dried blood spots. 23 Nov 2010

High quality diagnostic testing and manufacturing showcased at MEDICA
Contract manufacture services for lateral flow assays will be showcased at MEDICA this month by York-based  company Forsite Diagnostics. 11 Nov 2010

Barcode system to correctly identify patient samples
The Brenmoor PATscan system duplicates patient’s information from a printed wristband straight onto a label in less than a second, enabling correct identification of hospital samples. 25 Oct 2010

Welch Allyn launches handheld digital blood pressure device to world markets
Welch Allyn has introduced the Connex ProBP 3400, an automated digital blood pressure device designed to fit in the palm of the hand.
It provides a portable option for capturing reliable blood pressure readings in virtually any hospital or primary care environment. 21 Oct 2010 Deutsch Français Español

St George's Hospital selects MDI's PCR-based assay for MRSA screening
Molecular Detection Inc's Detect-Ready MRSA assay has received its first independent validation in a study conducted at St George's Healthcare NHS Trust, London, which is now using it for screening. 21 Oct 2010

UK government announces £50m funding for personalised medicine
The Stratified Medicines Innovation Platform is a new government initiative providing over £50 million of funding for research and development in diagnostics and pharmaceuticals for personalised medicine. 15 Oct 2010

GATC Biotech first in Europe to use PacBio RS gene sequencer
German gene sequencing service provider GATC Biotech has announced that it has agreed to purchase the PacBio RS platform, a single molecule, real-time (SMRT) gene sequencing technology. 11 Oct 2010

Friarage Hospital improves workflow for chemistry and immunoassay testing
Friarage Hospital in Yorkshire has installed the UK’s first VersaCell sample management system combining chemistry and immunoassay analysers from Siemens Healthcare Diagnostics. 11 Oct 2010

LabCorp in $925m takeover of Genzyme Genetics
Laboratory Corporation of America Holdings has agreed to acquire Genzyme Genetics, a business unit of Genzyme Corp and a leading provider of complex reproductive and oncology testing services. 15 Sept 2010

MIRACLE project lab-on-chip systemMIRACLE project launched to develop lab-on-chip for cancer diagnosis
The EU funded MIRACLE project, launched on 1 September, aims to develop an operational lab-on-chip for the isolation and detection of circulating and disseminated tumour cells in blood. 3 Sept 2010

Siemens introduces new systems for the diagnosis and therapy of heart diseases
Siemens Healthcare is presenting at the European Society of Cardiology Congress 2010 a range of innovative solutions for cardiology that provide higher quality of care and contribute at the same time to reducing costs in healthcare. 1 Sept 2010

Spartan Bioscience announces first point-of-care DNA testing system for personalized medicine
The Spartan RX, a complete sample-to-result, point-of-care DNA testing system for personalized medicine. The non-invasive system provides automated results in one hour. 18 August 2010

MabCure's blood test for ovarian cancer gets positive results
Cancer diagnostics developer MabCure, Inc. has announced that a confirmatory study demonstrated the company’s proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94% accuracy) and with no false positives or cross-reactions with benign ovarian tumours or healthy blood. 12 August 2010

Aloka e-flow technology improves accuracy of coronary heart diseases diagnosis
The Universidad Complutense de Madrid is using Aloka’s e-tracking technology to advance the early detection of cardiovascular events.
The system is used to easily measure predominant parameters on arterial vessels. 2 August 2010

BAE Systems wins $17m US army contract for head-worn brain injury sensor
BAE Systems has received an initial order of $17 million from the US Army for its Headborne Energy Analysis and Diagnostic Systems (HEADS) to help address combat-related traumatic brain injuries (TBI) in Iran and Iraq. 14 July 2010

FDA approves test for early diagnosis of AIDS from HIV antigen
The US FDA has approved an innovative new diagnostic tool from Abbott that can detect the AIDS antigen and give a diagnosis of AIDS earlier than ever before. 14 July 2010

Computerised blood pressure diagnosis beats hypertension experts
Irish Company dabl’s computerised system for diagnosing 24-hour blood pressure is more accurate and consistent than a leading group of international hypertension experts, according to an independent study. 30 June 2010

Ingen launches in vitro diagnostic kit for joint replacement infections
Ingen Biosciences has launched in Europe the first in vitro diagnostic kit to detect infections in prosthetic replacements. The diagnostic kit, BJI InoPlex, is built around Ingen Biosciences’ proprietary antigen technology. 30 June 2010

Simple urine test could diagnose autism
Children with autism have a different chemical fingerprint in their urine than non-autistic children. The finding could ultimately lead to a simple urine test to determine whether a child has autism. 18 June 2010

Ambry Genetics introduces test to identify carriers of newborn genetic disorders
Ambry Genetics has launched AmbryScreen, a genetic screening test used to identify carriers of some of the most severe and common childhood diseases affecting pan-ethnic populations. 14 June 2010

Blood test for detecting cancers five years before visible in diagnostic imaging
A ground-breaking diagnostic test that can identify biomarkers in blood for a range of cancers as much as five years earlier than current diagnostic imaging methods will be launched this month. 2 June 2010

Nanoscale glass conductors for new class of lab-on-chip devices
The discovery of a new electrical phenomenon that only acts at the nanoscale could lead to faster, less expensive lab-on-a-chip diagnostic devices. 24 May 2010

Novel rapid point-of-care test kits bring low cost diagnostics for HIV and AIDS
Low-cost test kits that measure CD4 T-cells in blood samples, markers of the immune system, will give HIV/AIDS patients access to antiretroviral drugs faster. 10 May 2010

Nanosensors powered by piezoelectric nanogenerators
By combining a new generation of piezoelectric nanogenerators with two types of nanowire sensors, researchers at the Georgia Institute of Technology have created what are believed to be the first self-powered nanometer-scale sensing devices that draw power from the conversion of mechanical energy. 21 April 2010

Siemens expands Clinitek point of care urinalysis porfolio
Siemens Healthcare Diagnostics has launched the Clinitek Status+ Analyser and the Clinitek Status Connect System for urinalysis and pregnancy testing at the point of care. 2 April 2010

Promega Maxwell 16 in vitro diagnostics system gains EU approval
The Promega Maxwell 16 IVD System has gained the CE marked for in vitro diagnostic medical devices. The CE mark applies to the instrument, the Maxwell 16 Blood DNA Purification System and the Maxwell 16 Viral Total Nucleic Acid Purification System. 2 April 2010

Alliance Biosciences provides HIV and TB biosafety guidance to Kenyan orphanage
Alliance Biosciences has reached an agreement with the Nyumbani Children's Home in Kenya to provide engineering and biosafety guidance to Nyumbani's planned HIV/TB diagnostic facility. 9 March 2010

Diagnostic Hybrids receives FDA emergency use authorization for H1N1 influenza A virus ID kit
The kit is a monoclonal antibody fluorescent staining kit for the specific identification of 2009 H1N1 influenza A in direct patient specimens or incubated tissue cultures. 9 Mar 2010

Sebia launches Capillarys 2 Flex Piercing for diagnostics labs
Sebia has unveiled the latest addition to its automated capillary electrophoresis portfolio, the innovative Capillarys 2 Flex Piercing for clinical diagnostic laboratories. 5 Mar 2010

PositiveID acquires non-invasive glucose detection technology with takeover of Easy Check
PositiveID Corporation has acquired intellectual property rights and assets of Easy Check Medical Diagnostics, LLC, to expand its portfolio of non-invasive glucose-level testing products and diabetes management tools under development. 23 Feb 2010

Chip for measuring male fertility is first stage in home testing kit
A new ‘fertility chip’, developed by researchers at the University of Twente’s is an important step towards the development of a compact device for reliable ‘pre-scanning’ of male fertility. 23 Feb 2010

Robotic patient helps Bath pharmacy students practice diagnosis
A robot that can be programmed to have a range of medical conditions, from heart disease to constipation, is being used by pharmacy students at the University of Bath to help practise diagnostic skills and treating patients. 23 Feb 2010

Femtomedicine — the new frontier of biomedical sciences
Femto-neutrons or ‘femtons’ are fast neutrons of femtometer wavelength — a million times smaller than nano scale — that can be used for a completely new rapid method of cancer diagnostics. 15 Feb 2010

Antibody-coated nanoparticles in microfluidic chip improve cancer detection 100 fold
The Fraunhofer Institute for Silicate Research is developing a highly sensitive method for detecting cancer that can detect single molecules of compounds in the blood that accompany specific types of tumour. 5 Feb 2010

Converging nanotechnology with the life science industry: Nano4Life 2010
Organised by NanoKTN in collaboration with The Wellcome Trust, the conference will be held in London on 4 Feb. 1 February 2010

The RFID sensor next to a US pennyGE develops wearable RFID sensor to detect airborne chemical agents
GE Global Research has been awarded US$2 million to develop wearable RFID sensors to alert people to the presence of environmental chemical agents in the air and signs of disease present in exhaled breath. 9 Dec 2009

Welch Allyn converges diagnostics with  electronic connectivity
Welch Allyn showcased its newest suite of core diagnostics product offerings with next-generation electronic connectivity at Medica 2009 in Dusseldorf last week. 4 Dec 2009

IBM creates rapid diagnostic testing system on a chip
Researchers at IBM's Zurich labs  have created a point-of-care diagnostic test system based on microfluidics on a silicon chip. The lab-on-a-chip requires less sample volume, is significantly faster, portable, easy to use and can test for many diseases. 18 Nov 2009 Deutsch

Diagnostic Hybrids gains FDA clearance for influenza A and B virus identification kit
Diagnostic Hybrids has announced FDA (510k) clearance of its D3 FastPoint L-DFATM Influenza A/ Influenza B Virus Identification Kit. 13 Nov 2009

Manhattan Scientifics and Senior Scientifics collaborate to develop cancer cell detection system
Manhattan Scientifics and Senior Scientific, LLC are co-operating to commercialize Senior Scientific’s magnetic needle leukemia cancer cell detection invention based on the use of nanoparticles. 12 Nov 2009

Zilico to exhibit pioneering device for rapid detection of cervical cancer at Medica
A pioneering device that offers a quicker, more accurate detection of cervical cancer in real time, removing several weeks of waiting for a diagnosis, is being exhibited by British company Zilico Ltd for the first time at Medica 2009. 3 Nov 2009

High precision analyser for medical and military applications
Revolutionary technology for analysis of chemical and biological substances developed at the University of Delaware holds promise in multiple applications, ranging from the early detection of diseases, to monitoring for chemical weapons and environmental pollutants. 3 November 2009

FDA publishes guidance on developing diagnostic tests for 2009 H1N1 flu virus
During a pandemic manufacturers can submit a request to the FDA for an Emergency Use Authorization to allow unapproved tests that meet certain criteria to be used for diagnosis. 3 Nov 2009

eBioscience acquires Bender MedSystems' immunoassay technology
eBioscience Corporation has acquired privately held Austrian immunoassay technology pioneer Bender MedSystems GmbH in an all cash transaction. 27 Oct 2009

High tech gas sensors for premium cars turned into diagnostic device for human diseases
High-tech gas sensors normally used to test components for premium cars have been used by researchers at Warwick University to analyse human blood and urine, and even cow dung samples to test their feasibility for diagnosing diseases. 28 Oct 2009

Cepheid wins grant to develop ten-colour real-time PCR detection technology
Cepheid has received a notice of grant award from the US National Institute of Allergy and Infectious Diseases to develop new ten-colour detection technology for use in its GeneXpert System. 27 October 2009

Siemens wins $135 million service contract from US health system
The University of Pennsylvania Health System has awarded Siemens Healthcare a $135 million contract for integrated service management for diagnostic systems and bio-medical devices. 21 Oct 2009 Deutsch

Breakthrough in lab-on-chip for fast breast cancer detection
The EU-funded MASCOT project has developed a set of modular components for construction of a lab-on-chip system for detection of tumour cells in blood samples. The modules are now ready for integration into a single lab-on-chip and clinical evaluation. 14 Oct 2009

Claros Diagnostics receives ISO 13485 certification for point-of-care blood-test system
Claros Diagnostics, a developer of novel point-of-care immunoassay systems, has reported the receipt of corporate ISO 13485 and CMDCAS certificates of registration issued by the National Standards Authority of Ireland (NSAI). 14 October 2009

Blood flow blockages in heart measured using wireless fractional flow reserve technology
St Jude Medical, Inc. has announced the first use of the PressureWire Aeris technology, an interventional tool which measures Fractional Flow Reserve (FFR) to evaluate the severity of blood flow blockages in the arteries. 13 Oct 2009

Philips develops breakthrough photomultiplier for medical imaging and diagnostics
Royal Philips Electronics (NYSE: PHG, AEX: PHI) has announced that its scientists have developed a highly innovative digital silicon photomultiplier technology that will allow faster and more accurate photon (the basic quantum unit of light) counting in a wide range of applications where ultra-low light levels need to be measured.8 October 2009

Promising results for rapid viral diagnosis tests in emergency rooms
Rapid viral diagnosis tests for respiratory diseases in children who arrive in emergency departments have the potential to reduce pressures on health systems by enabling doctors to reach a quicker diagnosis, according to Cochrane Researchers. 5 Oct 2009

New test identifies active TB in smear-negative patients
Researchers in the Tuberculosis Network European Trialsgroup have found that the enzyme-linked immunospot assay (ELISpot) can detect active tuberculosis in patients with negative sputum tests and give test results in one day. 5 Oct 2009

Breast cancer detector with a unique touch
Researchers at Drexel University in the US are developing a new portable, low-cost, breast cancer detector based on piezoelectric fingers that measure stiffness and mobility of breast tissue. 5 Oct 2009

UTAS chooses ADI Blackfin processors for patient monitoring and diagnostics devices
Patient  monitoring and diagnostics device manufacturer UTAS has selected Analog Devices' Blackfin processors to ensure high-performance digital signal processing operations and robust functionality across its full line of products. 2 Oct 2009

Cepheid accelerates development of rapid flu A panel test
Cepheid has announced the accelerated development of a Flu A Panel test for use on the GeneXpert System. The test will be designed to provide 45-minute identification of flu A infection, with specific presumptive identification of seasonal H1, seasonal H3, and H1N1 novel strain types. 22 Sept 2009

PrimerDesign develops world's first test kit for Tamiflu-resistant swine flu
Gene detection specialists PrimerDesign have developed a swine flu test kit that identifies the Tamiflu-resistant strain within 2 hours compared to the usual three days. 11 Sept 2009

PerkinElmer launches multiple steroid diagnostic kit for hormone and endocrine disorders
The Child Health System steroid profiling kit and data suite software can simultaneously measure ten different steroids in biological samples for diagnosing hormone imbalances or endocrine diseases in both children and adults. 10 September 2009

Diagnostic Hybrids releases Thyretain for specific detection of thyroid stimulating immunoglobulin
Thyretain is the first FDA-cleared test that specifically detects TSI and is to be used as an aid in the differential diagnosis of Graves’ disease, an autoimmune thyroid disorder.1 September 2009

Philips launches new cardiograph with rapid diagnosis
The PageWriter TC50 cardiograph offers an intuitive operation and advanced clinical decision support. 28 August 2009

Simple blood test may help predict risk of Alzheimer's
Scientists at UCLA have discovered a way to measure the amount of amyloid beta that is being absorbed by immune cells in the blood. If the immune system isn't adequately clearing amyloid beta, it may indicate Alzheimer's risk. A diagnostic blood test is now being developed for public use. 9 August 2009

Lab-on-a-chip analyses blood with optical detector
The EU-funded NEMOSLAB project is developing an integrated ‘lab on a chip’ that can simultaneously test a blood sample for several different molecules at the point of care. 24 July 2009

Luminex launches two new cystic fibrosis tests in Europe
The new xTAG tests will be used to provide assistance in cystic fibrosis screening for newborns and confirmatory diagnostic testing in newborns and children. The tests also can be used for carrier testing in adults of reproductive age. 17 July 2009

Availability of diagnostic tests drive success in hospital short-stay units
The most important factors for a successful stay in hospital short-stay units (SSUs) are the types of diagnostic tests performed and whether or not specialty consultations are needed. 29 June 2009

BRNI and Inverness Medical Innovations to develop commercial skin test to detect early Alzheimer's disease
The Blanchette Rockefeller Neurosciences Institute (BRNI) and Inverness Medical Innovations, Inc. (Inverness, NYSE:IMA) have announced that they will work together to further develop and commercialize a diagnostic test for Alzheimer's disease first discovered by scientists at BRNI. 18 June 2009

Vivacta raises US$4.5 million to commercialise piezofilm technology for point-of-care diagnostic tests
Kent-based diagnostic technology company Vivacta has announced that following successful development of its thyroid function test, it has closed a financing round that was fully subscribed by existing investors. 18 June 2009

Siemens develops RAPID2 system for fast discovery of pathogen signatures
Siemens Corporate Research has developed the RAPID2 system to speed the biomarker discovery process for the development of rapid diagnostic tests. This system marries the power of information technology with genomic sequencing to quickly identify genomic signatures unique to tested organisms. 16 June 2009

New peptide indicates Alzheimer's disease before brain is damaged
Researchers at Osaka University in Japan have discovered a peptide in cerebrospinal fluid (CSF) that can show whether a person is developing Alzheimer's disease. Measuring the level of this peptide could show that the disease process has started, long before any serious damage is done to the brain and allow early treatment. 10 June 2009

Report: Top Ten Global In-Vitro Diagnostics Companies
The global in-vitro diagnostics (IVD) market is forecast to grow at a rate of 6% to reach $50.0bn in 2012. Roche is the largest player in the market with a share of 20%. It is followed by Siemens and Abbott, who both hold 12% of the market. The IVD market is highly consolidated, with the top ten players holding close to 80% market share. A number of large in-vivo players have entered the IVD market recently, signalling the convergence of the two diagnostic fields. Siemens Healthcare is a prominent example of this trend, following their acquisition of DPC, Bayer Diagnostics and Dade Behring. more ...

UK company produces first DNA test kit for Mexican swine flu
PrimerDesign Ltd based in Southampton says it has won the race to produce the first DNA test kit for the Mexican swine flu A (H1N1). The rapid test gives results in only two hours compared to two days for current diagnostic tests. 11 May 2009

Proof-of-concept for breast cancer diagnostics shown for ExonHit's RNA splicing platform
Paris-based ExonHit Therapeutics has reported the publication in Lancet Oncology of a study conducted by Institut Gustave Roussy, which describes the identification of a deregulated cell function in breast cancer through the analysis of alternative RNA splicing. 23 March 2009

Lab21 acquires Biotec Laboratories
Lab21 Ltd of Cambridge, UK, has announced that it has purchased the majority shareholding of another UK company Biotec Laboratories Ltd, a clinical diagnostic company with particular emphasis on infectious diseases. 10 March 2009

Study on role of hormone oxytocin in causing autism
A research team at the Stanford University School of Medicine and Lucile Packard Children’s Hospital in the US will test whether impaired social behaviours in autism are linked to levels of the hormone. Preliminary research has hinted that autism may be associated with oxytocin deficits 2 March 2009

deCODE genetics offers cut-price genetic test for heart risks during February
deCODE genetics is offering its deCODEme Cardio Scan, a unique new tool that enables individuals to better understand their inherited risk of heart problems such as heart attack, stroke, abdominal aortic aneurysm, for $100. 12 February 2009

Non-invasive therapies and diagnostics on the increase
Non-invasive methods are on the increase for medical treatment, patient monitoring and diagnostics as they can help to avoid infections and mean less pain and stress for patients. 11 February 2009

Sysmex in agreement to distribute AdnaGen cancer diagnostic tests in Europe
Sysmex Europe GmbH and AdnaGen AG have entered into a non-exclusive European distribution agreement for AdnaGen proprietary CE-certified diagnostics as well as their research use only (RUO) products. 10 February 2009

Navigenics launches portal to give doctors access to patients' genomic information
For patients choosing to receive a Navigenics service through their physician, this portal allows the physician to integrate patients’ genetic information into personalized health plans designed to help diagnose early or prevent a number of health conditions. 10 February 2009

Novel cheap blood test for hepatitis C
A multinational team of researchers has developed a novel blood test that could bring a breakthrough in the battle against the dangerous hepatitis-C virus. This procedure offers a considerably cheaper alternative to the normal commercial tests, whilst maintaining equal sensitivity. 10 February 2009

EXACT Sciences in strategic relationship with Genzyme for DNA diagnostics technology
Genzyme has acquired intellectual property assets related to prenatal and reproductive health and three million shares of EXACT common stock for $24.5 million. 9 February 2009

New website shows benefits of piezofilm technology in diagnostics
The benefits of using piezofilm detection technology at the Point of Care are described on a new website launched by Vivacta, a developer of the technology. 31 January 2009

The malaria test cardMalaria diagnostic test on a card gives hope for developing countries
Researchers at the University of Washington have developed a prototype malaria test printed on a disposable Mylar card the size of a credit card. The key to the test is not only miniaturised lab-on-a-chip technology, but also the use of sugar to keep the dried reagent viable for months without refrigeration. 26 January 2009

Tyrian Diagnostics and Becton, Dickinson and Company complete feasibility study for tuberculosis diagnostic
Tyrian Diagnostics Limited has completed Milestone 4 of a feasibility study in collaboration with Becton, Dickinson and Company (BD) to determine the suitability of Tyrian’s proprietary tuberculosis (TB) protein markers for the development of rapid diagnostic tests to detect active TB disease. 22 January 2009

MicroPhage successfully completes beta trial for rapid MRSA test
MicroPhage has announced that its new bacterial identification test that rapidly identifies MRSA infections has concluded its first multicenter clinical trial. The company also reported the trial results have surpassed its early-stage performance expectations. 21 January 2009

Cheap reliable diagnosis for tuberculosis urgently needed
TB kills 2 million a year in developing countries and the threat of TB outbreaks even in Europe and North America costs these countries hundreds of millions of Euros to control every year. Yet the immediate, solvable challenge in TB is simply to diagnose the disease quickly and simply with robust, fully-tested kits. 8 January 2008

German innovation for HIV/AIDS diagnostics used 2.5 million times in 2008
During 2008, 2.5 million patient tests have been performed with Partec's CyFlow system, which is already supporting more than 1 million people living with HIV/AIDS. 17 December 2008

EU project developing DNA diagnostic device for doctor's desktop
The SMART-BIOMEMS project is developing a lab on a microfluidic chip that can be used in a portable diagnostic device to simultaneously and automatically analyse various DNA samples with high precision. 10 December 2008

Hospital on a chip could increase survival of battlefield wounded
Researchers in the US aim to develop an implantable biochip that could diagnose and provide medication to soldiers as soon as they are injured. Survival of battlefield wounds often depends on the level of treatment within the first 30 minutes, so providing instant treatment to wounded soldiers before a medic can reach them could increase chances of survival. 8 December 2008

Draeger DrugTest 5000 rapidly detects addictive drugs from saliva
The Dräger DrugTest 5000 can detect up to six different drug classes from samples of saliva within minutes. The system is compact, simple and hygienic to use. It also has data management capabilities to ensure sample documentation is easy to create. 26 November 20008

Philips announces breakthrough in point-of-care testing using nanotechnology
Philips’ new Magnotech technology uses magnetic nanoparticles to measure target molecules. The ease of use and accuracy of this new technology could speed up the diagnosis of life-threatening diseases and bring complex in-vitro diagnostic tests out of the laboratory to the patient’s bedside and at home. 25 November 2008

Nanogen partners with Menarini to market molecular diagnostic kits in Europe
Under the agreement, Menarini will commercialize CE marked IVD infectious disease kits based on Nanogen’s proprietary MGB technology. 12 November 2008

Radiometer adds NT-proBNP and Troponin T to its cardiovascular point-of-care portfolio
Radiometer has added assays for NT-proBNP and Troponin T to the panel of cardiovascular markers that can be assessed at the point of care using its new AQT90 FLEX POC immunoassay platform. 9 November 2008

Landmark 20-year study to assess impact of personal genetic testing
A US consortium is undertaking a first-of-its-kind study to assess the behavioural impact of personal genetic testing on up to 10,000 people to see how it affects their health and to identify their potential risk for developing certain diseases. 14 October 2008

bioMérieux to develop non-invasive test for prostate cancer
French in vitro diagnostics company bioMérieux has signed a license and development agreement with German biotechnology company ProteoSys for its novel prostate cancer marker Annexin 3, which will be used to develop a urine-based, confirmatory diagnostic test for prostate cancer. 2 October 2008 Francais

Enigma Diagnostics awarded £1.8 million to develop rapid DNA test for infectious diseases
Enigma Diagnostics will develop a 'gold-standard' portable, rapid, automated DNA analysis (PRADA) molecular test system for the diagnosis of infectious diseases in decentralised and point-of-care settings such as GP surgeries. 23 September

Agendia and Ferrer in sales agreement for cancer diagnostic services in European markets
Agendia BV and Ferrer inCode have announced an agreement that will give Ferrer exclusive rights to sell two of Agendia's signature cancer diagnostic services in Germany, France, Italy, and Portugal. 17 september 2008

Genetic testing can help predict treatment response in colorectal cancer
Genetic testing can identify a group of patients with advanced colorectal cancer who are likely to survive on average twice as long if treated with the drug cetuximab, new results have shown. 17 September 2008

Fairway Medical Technologies wins US Navy contract to develop battlefield blood-borne pathogen detector
Fairway Medical Technologies has received a $900,000 contract from the US Department of the Navy to apply its pulsed laser optoacoustic technology to the real-time detection of blood borne pathogens and biological warfare agents under battlefield conditions. 12 September 2008

Report: Molecular Diagnostics. Technologies, Markets and Companies
This best-selling report
describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. Aimed at chief executives and chief development officers, it is the most comprehensive and up-to-date one-stop source of information on technical and commercial aspects of molecular diagnostics. It includes profiles of 250 companies. 9 September 2008 more ...

Report: Point of Care Diagnostic Testing. World Markets
The report describes the specific market segment of the in vitro diagnostics market called point-of-care testing (POCT). It examines these clinical measurement devices and their reagents and supplies as utilized in near-patient environments like hospitals, clinics and doctor's offices. The study defines the dollar volume of sales, both worldwide and in the US, and analyzes the factors that influence the size and the growth of the market segments. more ... 9 September 2008

Protein microchip breakthrough could lead to rapid detection of diseases and drug discovery
A new method for attaching active proteins to biological microchips that could lead to rapid detection of disease and identification of new drugs has been developed by Scientists at the University of Manchester. 8 September 2008

Tepnel and SoftGenetics to offer rapid analytics for congenital disorders
Tepnel Life Sciences plc and SoftGenetics will market and distribute SoftGenetics GeneMarker genotyping software for use with Tepnel’s Elucigene QST*R products for prenatal detection of common chromosome abnormalities such as Down syndrome. 27 August 2008

DNA technology shows high sensitivity for colorectal cancer from stool sample
EXACT Sciences Corporation (NASDAQ: EXAS) has announced the results of a study that showed that improved 'BEAMing DNA' detection technology demonstrated 92% sensitivity for detecting colotectal cancer from stool samples. 27 August 2008

University of Twente awarded €2.4m grant for research into point-of-care diagnostics
The University of Twente in the Netherlands has been awarded a grant of €2.4 million euros from the European Research Council for its eLab4Life project that will research lab-on-a-chip systems for point-of-care diagnostics. 21 August 2008

Lab21 to market deCODE genetic tests for  common diseases in UK
Cambridge company Lab21 Limited has entered into a partnership with Icelandic company deCODE genetics, to offer deCODE’s tests for predisposition to a growing number of common diseases. 13 August 2008

Heritage Labs launches home diabetes test kit
US laboratory services company Heritage Labs has introduced a home testing kit for diabetics. The Appraise Home A1c Kit is a new at-home consumer product that measures the average blood glucose level of diabetics and potential diabetics. 13 August 2008

CHAD Therapeutics receives FDA clearance for sleep diagnostic device
Dormio Tech, a division of CHAD Therapeutics, Inc. has received 510(K) clearance from the FDA to market its FloChannel Diagnostic System in the USA. It is Dormio's first product for the sleep disorder market. 6 August 2008

Discovery of cardiovascular disease antibodies may lead to immunization
Low levels of naturally occurring antibodies may represent an increased risk of developing cardiovascular disease, particularly stroke in men. This discovery, published in the journal Atherosclerosis, has now led to attempts to develop an immunization against cardiovascular disease. 6 August 2008

Precise low-dose drug monitoring essential for long-term kidney transplant success
The ability of blood tests to precisely measure very low doses of anti-rejection drugs in kidney transplant patients may make a significant difference in assuring long-term viability and survival, according to research presented at the American Association for Clinical Chemistry (AACC) annual meeting last week. 6 August 2008

Kit for rapid assembly of lab-on-a-chip
University of Michigan engineers engineers have developed a kit for researchers to make custom microfluidic devices. The 16-piece lab-on-a-chip kit will bring microfluidic devices to researchers that don't have the funds, technology or skills to design and manufacture them from scratch. 5 August 2008

Abbott invests further US$20M in Ibis Biosciences' biosensor platform
The investment will allow Ibis to further develop the Ibis T5000 Biosensor System, which offers a unique solution for rapid identification and characterization of infectious agents, such as bacteria, viruses and fungi. 30 July 2008

Osmetech receives FDA clearance for warfarin sensitivity test
Molecular diagnostics company Osmetech plc has received 510(k) clearance from the US Food & Drug Administration for its eSensor Warfarin sensitivity test to be used as an aid in the identification of patients at risk for increased sensitivity to the widely used blood-thinning drug, warfarin. 30 July 2008

BD gains EU approval for Clostridium difficile diagnostic test
BD Diagnostics has gained EU approval for its GeneOhm Cdiff molecular assay for the rapid diagnosis of patients with Clostridium difficile infection (CDI). The test combines high assay sensitivity with a rapid turnaround time of less than two hours. 16 July 2008

Vivacta gears up for pilot manufacture of piezofilm assays
Vivacta is gearing up for pilot manufacture of its highly sensitive, disposable piezofilm sensors for point of care (PoC) diagnostics by acquiring an extra 6,000 sq ft of space within its facility at Kent Science Park. 10 July 2008

New type of ultraviolet diode could lead to compact anthrax detector
A new class of ultraviolet photodiode could make possible a compact, reliable and cost-effective sensor to detect anthrax and other bioterrorism agents in the air. 29 June 2008

Johnson & Johnson acquires Swedish in vitro diagnostic technology company Amic
Johnson & Johnson Nordic AB, a Johnson & Johnson company, has acquired Amic, a privately held Swedish developer of in vitro diagnostic technologies for use in point-of-care and near-patient settings. 19 June 2008

Multidetector CT scan can detect dissolved drugs
The smuggling of dissolved drugs, especially cocaine, in bottled liquids can be decreased with the use of multidetector CT according to a recent study conducted at Bern University. 3 June 2008

Quest Diagnostics collaborates with Google to provide diagnostic test results online
Doctors can securely provide diagnostic data with a brief explanation of test results to a patient's Google Health account. The system is expected to empower patients and physicians to collaborate more closely in making more well-informed healthcare decisions. 3 June 2008

Siemens and LabCorp to co-develop clinical diagnostic tests
Siemens Healthcare and Laboratory Corporation of America Holdings (LabCorp) have announced that they are exploring possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes. 12 May

Cranfield University tries new approach to TB diagnosis with breath test
A project to develop new technology for TB diagnosis will search for markers given off in volatile gases, such as breath, and program the data into existing portable devices, such as artificial noses, to provide a new screening method for the rapidly spreading disease. 29 April 2008

The 3-D structure of the immunoglobulin locus in B cellsFirst 3-D image of antibody gene
Scientists at the University of California, San Diego have shown for the first time how a genome is organized in three-dimensional space. They used a multidisciplinary mix of geometry, biological research and techniques developed to solve problems on supercomputers. 29 April 2008

Valdemar Hospital establishes point-of-care testing system
The Valdemar Private Hospital in Ringsted, Denmark, has invested in a point-of-care testing (POCT) service from Capio Diagnostics. The service includes remote monitoring and management of the POCT testing at the hospital from Capio Diagnostics’ monitoring centre in the UK. 17 April 2008

Dutch molecular medicine institute allocates 150m for disease research
The Center for Translational Molecular Medicine (CTMM) in Eindhoven has awarded 150 million of funding for nine research projects directed at the most prevalent diseases in the cardiovascular area, cancer and neurodegeneration. 7 April 2008

A prototype sensor for measuring electrolyte concentration in sweatSmart clothing with fluid biosensors to monitor health
The European BIOTEX project has produced textiles with woven-in miniaturised biosensors that can analyse body fluids such as sweat to assess the wearer's state of health. 31 March 2008

New breast cancer test uses magnetic nanoparticles to detect cancer cells
A team from University College London has developed a new medical device called the ‘HistoMag’ that will make the early detection of breast cancer more accurate, cost effective and easier to administer. 10 March 2008

Chest to distribute Aerocrine airway inflammation detector in Japan
Swedish airway products company Aerocrine AB has entered into a distribution agreement with Chest MI Inc to market and sell Aerocrine's Niox Mino in Japan. 20 February 2008

DNA test for assessing risk of prostate cancer
deCODE genetics has launched a test that can identify genetic markers associated with increased risk of prostate cancer. The company believes the test will better predict the risk of prostate cancer and help to optimize both screening and treatment. 20 February 2008

Acrongenomics targets Molecular Vision's microfluidics point-of-care diagnostics devices
Swiss technology investment group Acrongenomics, Inc. has announced an agreement with with Molecular Vision and The Imperial Venture Fund to acquire Molecular Vision by the end of the first quarter this year. 15 February 2008

A smart hologramSmart holograms help self-diagnosis for patients
Patients with chronic diseases such as diabetes, cardiac problems, kidney disorders or high blood pressure could benefit from the development of sensors made from a new type of hologram. 4 February 2008

Roche increases diagnostics capability with acquisition of Ventana
Pharmaceutical and diagnostics company Roche has bought US diagnostics company Ventana Medical Systems for about $3.4 billion. 30 January

Summit on revolution in personalised medicine caused by molecular diagnostics advances
Recent advances in genetic knowledge are transforming molecular imaging, molecular diagnostics and informatics to create stunningly precise diagnostic tools capable of assessing and treating a growing number of critical diseases. The first international Molecular Summit on 5-6 February will address this revolution in medicine. 30 January

Sysmex and bioMérieux form joint venture for Japanese diagnostics market
Sysmex Corporation will take a 34% equity stake in bioMérieux Japan Ltd, which will change its name to Sysmex bioMérieux Co Ltd. The new company will market bioMérieux in-vitro diagnostics products Japan. 30 January 2008

Quidel and bioMérieux form alliance in rapid diagnostics
Quidel Corporation and bioMérieux have formed an alliance to market products worldwide and co-develop new rapid diagnostic tests using Quidel’s rapid test development capability and bioMérieux’s extensive library of antibodies and antigens. 16 January

Cepheid launches GeneXpert molecular diagnostic system
Cepheid has begun shipment of its next generation GeneXpert self-contained automated molecular analysis system. It automates and integrates DNA testing and can test 60 targets in a single cartridge. 16 January

Siemens introduces MicroScan WalkAway plus automated diagnostic systems
Siemens Medical Solutions Diagnostics has introduced the MicroScan WalkAway plus Systems for mid- and high-volume clinical diagnostic microbiology laboratories. They offer simultaneous automation of overnight, rapid and specialty panels that test for both gram negative and gram positive bacteria. 16 January

BD gains EU and US approval for rapid MRSA test
BD Diagnostics has gained European approval for its BD GeneOhm StaphSR assay for MRSA and SA in nasal and wound specimens and US FDA clearance to use the test on positive blood cultures. The test can give results in two hours. 16 January

Glowing molecule detects prion diseases
An international team of researchers has developed a method of identifying prion and other defective-protein diseases using a fluorescent molecule that changes colour according to the disease present. 4 December 2007

Breakthrough in high sensitivity tuberculosis and malaria diagnosis
A new diagnostic system for detecting TB and malaria and suitable for use in developing countries and remote areas has been developed by German company Partec. The system combines Partec's battery-operated and mobile fluorescence microscope with dedicated test kits developed by Merck. 4 December 2007

Quest Diagnostics' blood and herpes point-of-care tests receive FDA clearance
Quest Diagnostics Incorporated (NYSE:DGX) has announced that its HemoCue and Focus Diagnostics subsidiaries have received FDA 510(k) clearance for two new point-of-care test kits that could speed up the time for diagnosis and allow doctors to make immediate decisions about treatment. 21 November 2007

The bird flu biosensorNew sensor detects bird flu in minutes
A new biosensor developed at the Georgia Tech Research Institute  can detect bird flu in just minutes. The biosensor is economical, field-deployable, sensitive to different viral strains and requires no labels or reagents. 17 October 2007

New laser method helps detect hidden liquid explosives and disease
A new and powerful technique that can detect hidden liquid explosives through common plastic containers and glass bottles has been demonstrated by scientists from the UK's Rutherford Appleton Laboratory. 8 October.

The Rosetta mission's mass spectrometerCometary spectrometer targets tuberculosis
A miniature mass spectrometer system, designed for the analysis of samples of a comet on the European Space Agency Rosetta mission is being adapted into a cost-effective, rapid and accurate tool for diagnosing tuberculosis (TB). 8 October

Gene sequencing identifies virus as possible cause of honeybee catastrophe
Researchers at Columbia University, in collaboration with 454 Life Sciences, a Roche company, have identified a virus implicated in the deaths of millions of honeybee colonies using the company's genome sequencer system. 1 October 2007

Molecular vision in collaboration to produce diagnostic device
Geneva. Molecular Vision Ltd, an offshoot from Imperial College, London, has teamed up with Acrongenomics Inc and design company Pearson Matthews Ltd to develop a point-of-care medical diagnostic device for detecting kidney and cardiac biomarkers. 4 July 2007

Cellestis launches online service for new blood test for TB
Australian medical diagnostics company Cellestis has created a website to provide worldwide information on the availability of its QFT test for TB. 3 July 2007

The SCOUT DS diabetes screening systemNon-invasive diabetes detector unveiled
VeraLight Inc. has introduced an experimental device that uses light-induced fluorescence to detect diabetes-related biomarkers found in skin. 2 July 2007

Bacteria place nanoparticles in cells to aid diagnosis or treatment
The natural infection mechanism of bacteria can be used to deliver nanoparticles carrying drugs, DNA or sensors into cells for precise diagnosis or treatment of disease. 19 June 2007

DiaGenic developing blood test for Alzheimer’s disease
Using peripheral blood as an easy-to-collect sample, the test detects a 'gene signature' of the disease. 11 June 2007

Inverness Medical Innovations and Procter & Gamble set up consumer diagnostics company
Inverness Medical Innovations, Inc. and The Procter & Gamble Company have completed their previously announced deal to form a joint venture for consumer diagnostic products, SPD Swiss Precision Diagnostics GmbH. 30 May 2007

Concentrating viral particles in electric field could lead to rapid virus detector
Engineers in the US have solved a critical bottleneck in the transport and capture of virus nanoparticles, making possible a device that could rapidly sample and detect infectious biological agents, such as viruses. 9 May 2007

Sensor identifies trace samples of cells and proteins in minutes
The sensor, which contains a millimeter-size cantilever, could have wide applications in medical diagnostic testing, detecting contamination in food products and monitoring for biothreat agents.

3M Health Care launches diagnostics unit for rapid detection of infection
3M Health Care has created a new Medical Diagnostics business unit to develop and commercialize rapid diagnostic products for detecting key infectious pathogens such as MRSA and other treatment-resistant microbes. 28 March 2007

Carbon nanotube coated with platinumPlatinum-coated nanotube biosensor detects glucose in near real time
Researchers at the University of Arkansas have fabricated a novel biosensor that detects glucose in close to real time and with much greater sensitivity than other comparable, biocompatible sensors. 21 March 2007

BioLED lab-on-chip technology to be demonstrated at Imperial College, London
A demonstration version of the BioLED Lab On A Chip platform combining microfluidics, organic semiconductor diodes and photodetectors will be presented to a selected audience. 21 February 2007

3M takes over UK rapid diagnostics company Acolyte Biomedica
The addition of Acolyte Biomedica allows 3M to expand more quickly into the emerging market of infection prevention diagnostics, especially in Europe where Acolyte Biomedica has a commercialized product for MRSA detection. 20 February 2007

Global molecular diagnostics market could reach $92bn by 2016
The market will be driven by the addition of new tests in high-volume testing areas coupled with the introduction of new instrumentation which will provide greater ease, speed, and quality. 15 February 2007.

Rapid flu testing decreases antibiotic use
Rapid influenza testing is associated with reductions in the use of antibiotics in hospitalized adults, according to a study published on Archives of Internal Medicine online. 31 Jan 2007

US college wins grant to develop portable device to detect bird flu and bioterrorism agents
The Medical College of Wisconsin in Milwaukee has been awarded a five-year, $8.1 million grant from the National Institutes of Health’s Institute of Allergy and Infectious Diseases (NIAID) to develop a rapid, miniaturized, automated diagnostic device to test for avian flu and the majority of potential bioterrorism agents. 23 January 2007

Roche Diagnostics launches cobas e 411 immunoassay analyzer
Roche Diagnostics has released its next generation bench-top immunoassay analyzer, the cobas e 411 aimed at the low- to mid- volume immunoassay market. 15 Jan 2007

Point-of-care diagnostics market to surpass $16bn worldwide by 2010.
The demand for reduced costs and decentralized diagnostic testing in the US is driving the market, according to research from Kalorama Information. 18 December 2006

Cepheid wins $14.9m contract from US CDC for rapid detector of bird flu virus
Cepheid will develop a fully automated, self-contained test that will detect the common forms of flu virus (influenza A/B) as well as H5N1 in about 30 minutes. 15 Dec 2006

Siemens' take over of Bayer Diagnostics gains European approval
The €4.2 billion deal will allow Siemens' to combine its entire imaging diagnostics, laboratory diagnostics and clinical information technology value chain under one roof and create what the company claims is the world's first full service diagnostics company. 3 Nov 2006

Akubio wins £800,000 grant to develop electronic hand-held disease detectors
UK nanotechnology firm Akubio, has received a £826,000 government grant to help develop its electronic technology for the rapid detection of viruses and bacteria such as avian flu, E coli, malaria and meningitis. 24 Oct 2006

Electronic sensor to detect E coli
A sensor that can detect E coli bacteria within minutes by measuring changes in frequency of vibration of the detector is being developed at Drexel University in the USA. 24 Oct 2006

BD Biosciences releases flow cytometry system for in vitro diagnostics use. 27 Sept 2006

Disposable glass microchip for large-scale screening of diseases
Researchers in Virginia have developed a disposable microchip that replaces space-consuming instrumentation with fast, cost-effective, lab-on-a-chip technology. The microfluidic device is suitable for large-scale screening of disease-related biomarkers. 20 Sept 2006

Silicon 'nanocantilevers' form ultrasensitive biological detectors
The tiny vibrating silicon structures created by researchers at Purdue University vibrate at different frequencies when contaminants stick to them, revealing the presence of dangerous substances. 12 Sept 2006

Bayer Diagnostics launches immunoassay system. 8 Sept 2006

Paris University to study medical applications of NanoArrayer
The Université Pierre & Marie Curie (UPMC) in Paris is evaluating the BioForce Nanosciences NanoArrayer system. The University will use the NanoArrayer to pattern proteins associated with cell morphology establishment and migration. 24 August 2006

US approval for Abbott's fully automated blood screening tests for hepatitis
Abbott has received approval from the US FDA for its Prism hepatitis B surface antigen (HBsAg) and its Prism HBsAg confirmatory test. These tests can be used to screen donated blood for HBsAg. 26 July 2006

Light scattering off liver cells on photonic crystalLiver cells in silicon crystals screen drugs for toxicity
Researchers at the University of California, San Diego have developed a 'smart petri dish' that could be used to rapidly screen new drugs for toxic interactions or identify cells in the early stages of cancer circulating through a patient’s blood. 20 June 2006

Avian flu virus detector on a chip
BioWarn has demonstrated the capability to instantaneously detect avian influenza virus (H5N1), also known as bird flu, using its new SmartSense system. This combines biochemistry with silicon chip technology to make a molecular identikit system for pathogens and other materials. 12 June 2006

Nikon launches ultra sensitive camera for molecular fluorescence imaging
Nikon Instruments has introduced the Nikon EMCCD Monochrome Digital Camera (DQC-FS), an ultra high-quality camera specifically designed for low-level fluorescence such as single molecule fluorescence, high speed calcium imaging and live cell fluorescent protein imaging. 7 June 2006

Varian develops new probes for nuclear magnetic resonance of solid materials
Varian has launched the FastMAS and UltraFastMAS probes for analysing solid materials and the BioStatic probe for determining the molecular structures of proteins and other biomolecules in a solid state. 6 May 2006

Bruker Daltonics obtains Russian medical device registration for mass spectrometers
Bruker Daltonics has obtained registration of its complete MALDI-TOF product line of mass spectrometers, and its ClinProRobot sample preparation platform. This will allow the Institute of Physico-Chemical Medicine in Moscow to develop a novel system for the identification and characterization of clinically relevant microorganisms. 1 May 2006

Mass spectrometry used to detect norovirus pathogen in clinical samples
Researchers at Johns Hopkins University have demonstrated that proteomic mass spectrometry has the potential to be used to identify viruses in complex environmental samples. It has potential for use in biodefense and public health preparedness. 25 April 2006

Rapid avian flu detection kits
Applied Biosystems has released its TaqMan Influenza A/H5 Detection Kit  for sale in in Europe, Asia, and Africa. It is capable of rapidly and reliably detecting multiple strains of avian influenza in laboratory samples. 14 March 2006

Molecular imager for in-vitro imaging of protein biomarkers in tissue sections and cell clusters
Bruker Daltonics has launched the MALDI Molecular Imager for high-sensitivity imaging of the spatial distribution of protein biomarkers in biological, pathology and other clinical research. 14 March 2006

Hybrid sensor technology to revolutionize high-end spectroscopy
Princeton Instruments/ Acton has developedva hybrid sensor technology that combines the key benefits of both CCDS and CMOS sensors to yield a dedicated spectroscopy detector, that has unparalleled sensitivity and speed. 13 March 2006

Definiens launches automated image analyser for cell-based assays
Definiens has released Cellenger, a set of workflow tools and modular components for cellular image analysis based on cognition software developed for remote sensing. 10 February 2006

Molecular diagnostics market shows fast growth
Based on its exceptional ability to accurately detect the primary cause of disease, molecular diagnostics has emerged as the fastest growing segment of the in vitro diagnostics (IVD) industry. 11 January 2006

Nano-scale medical devices could be wired with unravelled DNA strands
Ohio State University researchers have uncoiled DNA strands and formed them into precise patterns. They could act as wires in biologically based nano-scale electronic and medical devices. 18 December 2005

University of Leeds pathology unit expands tissue scanning capacity
The University of Leeds Academic Unit of Pathology has increased its capacity to scan slides of tissue samples by acquiring five Aperio ScanScope virtual microscopy systems. These will support a broad array of initiatives, including potentially enabling primary diagnoses to be made without referring to the glass slide. 7 September 2005

Siemens takes over development of 'lab on a chip'
Siemens is taking over the development of an award-winning electrochemical biochip from its partners in the project. The transfer to Siemens involves patents, a high-tech biochip lab as well as experts with the know-how of silicon biochip manufacture. 23 June 2005

To top

To top